Sanofi
718 hedge funds and large institutions have $8.08B invested in Sanofi in 2026 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 210 increasing their positions, 297 reducing their positions, and 103 closing their positions.
0.81% less ownership
Funds ownership: 8.73% → 7.92% (-0.81%)
4% less funds holding
Funds holding: 746 → 718 (-28)
14% less first-time investments, than exits
New positions opened: 89 | Existing positions closed: 103
16% less call options, than puts
Call options by funds: $116M | Put options by funds: $138M
20% less capital invested
Capital invested by funds: $10.1B → $8.08B (-$2.02B)
29% less repeat investments, than reductions
Existing positions increased: 210 | Existing positions reduced: 297
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$70.2M |
| 2 |
JP Morgan Chase
New York
|
+$43.5M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$36.6M |
| 4 |
AC
Armistice Capital
New York
|
+$34.1M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$31.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$312M |
| 2 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
-$143M |
| 3 |
Morgan Stanley
New York
|
-$80.8M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$69.7M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
-$66.8M |
SNY Hedge Fund Activity: Q2 2026 in Review
718 of the 8,348 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2026, worth a combined $8.08B — down 20% from $10.1B a quarter earlier.
Sellers outnumbered buyers: 103 funds closed out of SNY and 89 opened new positions — a net loss of 14 holders — while 297 trimmed existing stakes and 210 added.
The largest buyer was Balyasny Asset Management, adding an estimated $70.2M. The largest seller was Franklin Resources, cutting an estimated $312M.
- 718 institutional investors held Sanofi (SNY) as of Q2 2026, down from 746 in Q1 2026.
- Funds reported $8.08B of Sanofi stock for Q2 2026, down 20% quarter-over-quarter.
- 89 funds opened new Sanofi positions in Q2 2026 and 103 closed out, a net change of -14 holders.
- The largest Sanofi buyer in Q2 2026 was Balyasny Asset Management, an estimated $70.2M added.
- The largest Sanofi seller in Q2 2026 was Franklin Resources, an estimated $312M sold.
Based on aggregated 13F filings for Q2 2026.